Tarsus Pharmaceuticals, Inc.
Nasdaq TARS · Irvine, CA
Works in Dermatology · Infectious disease · Ophthalmology
Tarsus Pharmaceuticals, Inc. is a clinical trial sponsor based in Irvine, CA, listed as Nasdaq TARS. It has 2 active clinical trials with 877 planned participants, in Dermatology, Infectious disease and Ophthalmology. Since 2021 it has completed 9 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq TARS
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Tarsus Pharmaceuticals, Inc
Tarsus Pharmaceuticals, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 877 planned participants, in Dermatology, Infectious disease, Ophthalmology. Since 2021 it has completed 9 trials and stopped 0 early.
Tarsus Pharmaceuticals, Inc is based in Irvine, CA and is listed as Nasdaq TARS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Tarsus Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-09.
Approve Suite is not affiliated with Tarsus Pharmaceuticals, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.